BC Innovations | Jun 18, 2019
Distillery Therapeutics

CAMKK2 identified as target for breast cancer

DISEASE CATEGORY: Cancer INDICATION: Breast cancer Inhibition of CAMKK2 could treat breast cancer. In patients, high tumor expression of CAMKK2 was associated with triple-negative breast cancer (TNBC) and low expression was associated with the less...
BC Innovations | May 2, 2013
Distillery Therapeutics

Indication: Neurology

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Alzheimer's disease (AD) AMP-activated protein kinase (AMPK); b-amyloid 42 (Ab42); calcium calmodulin-dependent protein kinase kinase 2 (CAMKK2) Mouse and cell culture...
Items per page:
1 - 2 of 2